About the Organization
The ACME Laboratories Ltd. is one of the largest and most established pharmaceutical companies in Bangladesh, with a heritage stretching back more than seven decades. It is one of the top-tier pharmaceutical companies in Bangladesh, currently manufacturing more than 800 products in different dosage forms covering broad therapeutic categories, with an established footprint both locally and around the globe. Its story began in the mid-twentieth century and is rooted in a founder's vision; the company traces its origins to Hamidur Rahman Sinha, an entrepreneur and philanthropist, and remains true to its founder's vision and values, producing high-quality medicines with integrity, customer focus, and a desire to win.
The company has steadily evolved its corporate structure over the years. Founded in 1954 as a proprietorship firm, it was converted into a private limited company on 17 March 1976, became a public limited company on 30 November 2011, and was listed on the Dhaka and Chittagong Stock Exchanges on 7 June 2016. It is part of the broader ACME Group of Companies and is led by Managing Director and largest shareholder Mizanur Rahman Sinha, with Nagina Afzal Sinha as chairperson, and is headquartered in Dhaka. The organisation is built around a clear purpose, drawing on the outstanding knowledge, professionalism, and commitment of more than 7,000 employees, with a mission to ensure health, vigour, and happiness for mankind, and is an ISO 9001:2015 certified company.
Business Operations
ACME's core business is the manufacturing, marketing, and distribution of pharmaceutical products. It produces medicines across broad therapeutic categories including anti-infective, cardiovascular, antidiabetic, gastrointestinal, central nervous system, and respiratory disease treatments, among many others. Its portfolio extends well beyond conventional human medicines; ACME covers a wide range of therapeutics spanning pharmaceutical, herbal and nutraceutical, ayurvedic, and veterinary products, including many sophisticated product lines. These are produced across an extensive array of dosage forms, from tablets, capsules, dry syrups, creams, ointments, injections, dry powder and metered dose inhalers, and eye and nasal drops, through to veterinary dosage forms such as boluses and water-soluble powders.
The company has built a meaningful international presence on the back of its domestic success. Its success in the local market prompted it to explore international markets, and over the years it has gained a firm presence in South East Asia, Africa, and Central America, continuously discovering new horizons to improve patients' quality of life. This global expansion has been supported by stringent regulatory credentials; ACME has received WHO Prequalification approval for its Zinc Dispersible Tablet, certification of GMP compliance from the UK's MHRA, and certification from Australia's Therapeutic Goods Administration, and has launched products in the US and UK markets.
Affiliations With BUP Career Club
ACME is a participating company at the BUP Career Club's flagship event. ACME is coming to the "BUP Career & Education Fest 2026" on 17th–18th May. This places ACME among the recruiters and industry organisations engaging directly with BUP students at the festival, the central purpose of the event, where students interact with employers, explore job and internship opportunities, and submit their CVs.
The participation reflects a strong, natural fit between the two organisations. The BUP Career Club works to create a bridge between the corporate world and the university, helping fresh graduates reach their desired professions while equipping students with the skills to stay ahead of the competition. As one of Bangladesh's largest pharmaceutical companies and a significant national employer with global operations, ACME offers BUP students exposure to careers across a major science-and-manufacturing sector, spanning sales and marketing, supply chain, quality and regulatory affairs, finance, and management, while the company gains access to a strong pool of business and professional graduates to support its continued growth.
